Clinical Trial Update: Non-Invasive Biomarkers in Prostate Cancer Disease Management

View source ↗

Summary

The trial 'Non-Invasive Biomarkers in Prostate Cancer Disease Management' sponsored by H. Lee Moffitt Cancer Center is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer | Status: SUSPENDED